EP3774790 - OXAZOLIDINONE ANTIBIOTIC COMPOUNDS AND PROCESS OF PREPARATION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.12.2023 Database last updated on 14.06.2024 | |
Former | The patent has been granted Status updated on 23.12.2022 | ||
Former | Grant of patent is intended Status updated on 16.08.2022 | ||
Former | Examination is in progress Status updated on 10.12.2021 | ||
Former | Request for examination was made Status updated on 15.01.2021 | ||
Former | The international publication has been made Status updated on 05.10.2019 | ||
Former | unknown Status updated on 11.05.2019 | Most recent event Tooltip | 09.02.2024 | Lapse of the patent in a contracting state New state(s): SI | published on 13.03.2024 [2024/11] | Applicant(s) | For all designated states Bugworks Research, Inc. 2711 Centerville Road, Suite 400 Wilmington, DE 19808 / US | [2021/07] | Inventor(s) | 01 /
PEER MOHAMED, Shahul Hameed Bugworks Research India Pvt. Ltd. EVOMA, 88 Borewell Road Whitefield, Bengaluru 560066 / IN | 02 /
BHARATHAM, Nagakumar Bugworks Research India Pvt. Ltd. EVOMA, 88 Borewell Road Whitefield, Bengaluru 560066 / IN | 03 /
KATAGIHALLIMATH, Nainesh Bugworks Research India Pvt. Ltd. EVOMA, 88 Borewell Road Whitefield, Bengaluru 560066 / IN | 04 /
SHARMA, Sreevalli Bugworks Research India Pvt. Ltd. EVOMA, 88 Borewell Road Whitefield, Bengaluru 560066 / IN | 05 /
NANDISHAIAH, Radha Bugworks Research India Pvt. Ltd. EVOMA, 88 Borewell Road Whitefield, Bengaluru 560066 / IN | 06 /
RAMACHANDRAN, Vasanthi Bugworks Research India Pvt. Ltd. EVOMA, 88 Borewell Road Whitefield, Bengaluru 560066 / IN | [2021/07] | Representative(s) | Jones, Nicholas Andrew Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [2023/04] |
Former [2021/07] | Jones, Nicholas Andrew Withers & Rogers LLP 4 More London Riverside London, SE1 2AU / GB | Application number, filing date | 19721148.5 | 28.03.2019 | [2021/07] | WO2019IN50252 | Priority number, date | IN201841011765 | 28.03.2018 Original published format: IN201841011765 | [2021/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019186590 | Date: | 03.10.2019 | Language: | EN | [2019/40] | Type: | A1 Application with search report | No.: | EP3774790 | Date: | 17.02.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.10.2019 takes the place of the publication of the European patent application. | [2021/07] | Type: | B1 Patent specification | No.: | EP3774790 | Date: | 25.01.2023 | Language: | EN | [2023/04] | Search report(s) | International search report - published on: | EP | 03.10.2019 | Classification | IPC: | C07D413/14, C07D417/04, C07D417/14, C07D471/04, C07D498/04, A61K31/536, A61K31/4985, A61K31/5365, A61K31/5377, A61K31/5386, A61P31/00 | [2021/07] | CPC: |
C07D413/14 (EP);
A61K31/542 (US);
A61K31/4985 (EP);
A61K31/5365 (EP);
A61K31/5377 (EP);
A61K31/5383 (US);
A61K31/5386 (EP);
A61P31/00 (EP);
A61P31/04 (US);
C07D417/04 (EP);
C07D417/14 (EP);
C07D471/04 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ANTIBIOTISCHE OXAZOLIDINONVERBINDUNGEN UND VERFAHREN ZUR HERSTELLUNG | [2021/07] | English: | OXAZOLIDINONE ANTIBIOTIC COMPOUNDS AND PROCESS OF PREPARATION | [2021/07] | French: | COMPOSÉS ANTIBIOTIQUES D'OXAZOLIDINONE ET PROCÉDÉS DE PRÉPARATION | [2021/07] | Entry into regional phase | 19.10.2020 | National basic fee paid | 19.10.2020 | Designation fee(s) paid | 19.10.2020 | Examination fee paid | Examination procedure | 19.10.2020 | Amendment by applicant (claims and/or description) | 19.10.2020 | Examination requested [2021/07] | 19.10.2020 | Date on which the examining division has become responsible | 13.12.2021 | Despatch of a communication from the examining division (Time limit: M04) | 13.04.2022 | Reply to a communication from the examining division | 10.05.2022 | Despatch of a communication from the examining division (Time limit: M02) | 13.07.2022 | Reply to a communication from the examining division | 17.08.2022 | Communication of intention to grant the patent | 19.12.2022 | Fee for grant paid | 19.12.2022 | Fee for publishing/printing paid | 19.12.2022 | Receipt of the translation of the claim(s) | Opposition(s) | 26.10.2023 | No opposition filed within time limit [2024/01] | Fees paid | Renewal fee | 19.10.2020 | Renewal fee patent year 03 | 18.03.2022 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | EE | 25.01.2023 | LT | 25.01.2023 | LV | 25.01.2023 | MC | 25.01.2023 | SI | 25.01.2023 | SK | 25.01.2023 | LU | 28.03.2023 | IS | 25.05.2023 | [2024/11] |
Former [2024/02] | EE | 25.01.2023 | |
LT | 25.01.2023 | ||
LV | 25.01.2023 | ||
MC | 25.01.2023 | ||
SK | 25.01.2023 | ||
LU | 28.03.2023 | ||
IS | 25.05.2023 | ||
Former [2023/50] | EE | 25.01.2023 | |
LT | 25.01.2023 | ||
LV | 25.01.2023 | ||
MC | 25.01.2023 | ||
SK | 25.01.2023 | ||
IS | 25.05.2023 | ||
Former [2023/48] | EE | 25.01.2023 | |
LT | 25.01.2023 | ||
LV | 25.01.2023 | ||
MC | 25.01.2023 | ||
IS | 25.05.2023 | ||
Former [2023/39] | LT | 25.01.2023 | |
LV | 25.01.2023 | ||
IS | 25.05.2023 | ||
Former [2023/36] | LT | 25.01.2023 | |
LV | 25.01.2023 | ||
Former [2023/33] | LT | 25.01.2023 | Cited in | International search | [Y]WO2008126024 (ACTELION PHARMACEUTICALS LTD [CH], et al) [Y] 1-19 * page 1, lines 2-7; page 9, line 5 to page 11, line 19; page 21, line 25; page 23, lines 3-7; page 77, Scheme 1, "I-3 + I-2 -> I-a"; page 78, Scheme 2; pages 274-275, "Pharmacological properties of the invention compounds" *; | [Y]WO2009104159 (ACTELION PHARMACEUTICALS LTD [CH], et al) [Y] 1-19 * page 2, line 6 to page 3, line 14; page 5, line 17 to page 6, line 1, e.g. group G5; page 18, line 28 to page 20, line 12; page 36, first reaction scheme (Ia) and (Ib); page 95, "Results" *; | [Y]WO2013021363 (ACTELION PHARMACEUTICALS LTD [CH], et al) [Y] 1-19* page 1, lines 1-6; page 7, compound of formula I; pages 36-40, e.g. reaction of compound IX with compound X to prepare compound XI or compound XII; pages 108-110, "Pharmacological properties of the invention compounds" *; | [Y]WO2017199265 (BUGWORKS RES INDIA PVT LTD [IN]) [Y] 1-19 * [0005]-[0006]; [00045]; [00058]; examples, e.g. Example 1, in particular the reaction scheme for preparing the compound of Example 1; pages 89-98, "Biological activity", e.g. Tables 1 to 3; claims, e.g. Claim 3 * | by applicant | WO2017199265 | WO2018225097 | - CHEMICAL ABSTRACTS, Database accession no. 2156619-15-5 | - CHEMICAL ABSTRACTS, Database accession no. 97859-49-9 |